Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Net Cash Flow: 2010-2024

Historic Net Cash Flow for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to -$764,365.

  • China Pharma Holdings' Net Cash Flow fell 1194.31% to -$399,799 in Q3 2025 from the same period last year, while for Sep 2025 it was -$417,862, marking a year-over-year increase of 37.78%. This contributed to the annual value of -$764,365 for FY2024, which is 19.80% down from last year.
  • As of FY2024, China Pharma Holdings' Net Cash Flow stood at -$764,365, which was down 19.80% from -$638,058 recorded in FY2023.
  • In the past 5 years, China Pharma Holdings' Net Cash Flow ranged from a high of $3.9 million in FY2021 and a low of -$2.6 million during FY2022.
  • Moreover, its 3-year median value for Net Cash Flow was -$764,365 (2024), whereas its average is -$1.3 million.
  • Per our database at Business Quant, China Pharma Holdings' Net Cash Flow surged by 1,470.00% in 2021 and then slumped by 166.03% in 2022.
  • Yearly analysis of 5 years shows China Pharma Holdings' Net Cash Flow stood at -$285,390 in 2020, then soared by 1,470.00% to $3.9 million in 2021, then crashed by 166.03% to -$2.6 million in 2022, then skyrocketed by 75.28% to -$638,058 in 2023, then dropped by 19.80% to -$764,365 in 2024.